Barclays’s Cross Country Healthcare CCRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $626K | Sell |
|
|||||
|
2025
Q2 | $762K | Buy |
|
|||||
|
2025
Q1 | $823K | Sell |
|
|||||
|
2024
Q4 | $1.31M | Sell |
|
|||||
|
2024
Q3 | $1.08M | Buy |
|
|||||
|
2024
Q2 | $511K | Sell |
|
|||||
|
2024
Q1 | $797K | Sell |
|
|||||
|
2023
Q4 | $1.77M | Buy |
|
|||||
|
2023
Q3 | $1.07M | Buy |
|
|||||
|
2023
Q2 | $885K | Buy |
|
|||||
|
2023
Q1 | $585K | Buy |
|
|||||
|
2022
Q4 | $648K | Buy |
|
|||||
|
2022
Q3 | $352K | Sell |
|
|||||
|
2022
Q2 | $486K | Sell |
|
|||||
|
2022
Q1 | $831K | Sell |
|
|||||
|
2021
Q4 | $1.3M | Buy |
|
|||||
|
2021
Q3 | $690K | Buy |
|
|||||
|
2021
Q2 | $304K | Sell |
|
|||||
|
2021
Q1 | $553K | Buy |
|
|||||
|
2020
Q4 | $345K | Sell |
|
|||||
|
2020
Q3 | $278K | Buy |
|
|||||
|
2020
Q2 | $204K | Buy |
|
|||||
|
2020
Q1 | $203K | Sell |
|
|||||
|
2019
Q4 | $633K | Buy |
|
|||||
|
2019
Q3 | $377K | Sell |
|
|||||
|
2019
Q2 | $391K | Buy |
|
|||||
|
2019
Q1 | $213K | Buy |
|
|||||
|
2018
Q4 | $112K | Sell |
|
|||||
|
2018
Q3 | $341K | Buy |
|
|||||
|
2018
Q2 | $212K | Buy |
|
|||||
|
2018
Q1 | $136K | Buy |
|
|||||
|
2017
Q4 | $72K | Buy |
|
|||||
|
2017
Q3 | $17K | Sell |
|
|||||
|
2017
Q2 | $49K | Sell |
|
|||||
|
2017
Q1 | $161K | Buy |
|
|||||
|
2016
Q4 | $164K | Buy |
|
|||||
|
2016
Q3 | $7K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $431K | Sell |
|
|||||
|
2015
Q4 | $666K | Buy |
|
|||||
|
2015
Q3 | $2K | Sell |
|
|||||
|
2015
Q2 | $7K | Sell |
|
|||||
|
2015
Q1 | $11K | Sell |
|
|||||
|
2014
Q4 | $30K | Sell |
|
|||||
|
2014
Q3 | $131K | Sell |
|
|||||
|
2014
Q2 | $106K | Sell |
|
|||||
|
2014
Q1 | $167K | Buy |
|
|||||
|
2013
Q4 | $116K | Sell |
|
|||||
|
2013
Q3 | $92K | Sell |
|
|||||
|
2013
Q2 | $112K | Buy |
|